PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.

MLA

Zheng, Qian-Wen, et al. “PPDPF Promotes Lung Adenocarcinoma Progression via Inhibiting Apoptosis and NK Cell-Mediated Cytotoxicity through STAT3.” Oncogene, vol. 41, no. 36, Sept. 2022, pp. 4244–56. EBSCOhost, https://doi.org/10.1038/s41388-022-02418-3.

APA

Zheng, Q.-W., Ni, Q.-Z., Zhu, B., Liang, X., Ma, N., Wang, Y.-K., Xu, S., Cao, H.-J., Xia, J., Zhang, F.-K., Zhang, E.-B., Qiu, X.-S., Ding, X.-F., Qiu, L., Zhang, X.-L., Dong, Z.-H., Li, Z.-G., Zhang, X.-L., Xie, D., & Li, J.-J. (2022). PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3. Oncogene, 41(36), 4244–4256. https://doi.org/10.1038/s41388-022-02418-3

Chicago

Zheng, Qian-Wen, Qian-Zhi Ni, Bing Zhu, Xin Liang, Ning Ma, Yi-Kang Wang, Sheng Xu, et al. 2022. “PPDPF Promotes Lung Adenocarcinoma Progression via Inhibiting Apoptosis and NK Cell-Mediated Cytotoxicity through STAT3.” Oncogene 41 (36): 4244–56. doi:10.1038/s41388-022-02418-3.